Ocean Biomedical, Inc.
OCEA- Exchange
- OTC
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001869974
No open-market purchases or sales by Ocean Biomedical, Inc. insiders were filed in the last 90 days; 1 institution reported holding it in 13F filings for Q2 2026, worth $0 in total; no superinvestor holds it.
Q3 2022 vs. Q2 2022
How the institutions holding Ocean Biomedical, Inc. changed between Q2 2022 and Q3 2022.
All holders in Q3 2022All holders in Q2 2022
| Measure | Q2 2022 | Q3 2022 | Change |
|---|---|---|---|
| Holders | 35 | 40 | +5 |
| Shares | 10.2M | 10.4M | +217.1K (+2.1%) |
| Value | $102.9M | $105.9M | +$3.00M (+2.9%) |
New holders (8)
Institutions that held Ocean Biomedical, Inc. at the end of Q3 2022 but not at the end of Q2 2022.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Polar Asset Management Partners Inc. | 825,000 | $8.41M | 0.11% |
| Woodline Partners LP | 225,000 | $2.29M | 0.03% |
| Meteora Capital, LLC | 138,757 | $1.41M | 0.36% |
| Calamos Advisors LLC | 125,000 | $1.27M | 0.01% |
| Whitebox Advisors LLC | 102,800 | $1.05M | 0.03% |
| Landscape Capital Management, L.L.C. | 72,600 | $740.0K | 0.10% |
| Highbridge Capital Management LLC | 35,015 | $357.0K | 0.01% |
| Elequin Capital LP | 259 | $3.00K | 0.00% |
Sold out (3)
Institutions that held Ocean Biomedical, Inc. at the end of Q2 2022 and filed for Q3 2022 without it.
| Institution | Shares, Q2 2022 | Value, Q2 2022 |
|---|---|---|
| Mizuho Securities USA LLC | 668,429 | $6.68M |
| Pinz Capital Management, LP | 60,000 | $607.0K |
| Goldman Sachs Group Inc | 36,000 | $364.0K |